[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$xncr Graphic](https://lunarcrush.com/gi/w:26/t:$xncr.png) $xncr

Xencor sees increased social engagement, but a negative rating from Barclays may cause short-term volatility. Positive mentions and analyst ratings provide some support for the stock's outlook, however, the negative rating is likely to cause volatility in the short term.

### About $xncr
Xencor, Inc. (XNCR) is a biotechnology company.  

### Insights [#](/topic/$xncr/insights)
- $xncr engagements is up XXX% from the previous week.
- $xncr posts created is up XXX% from the previous week.

### Engagements: XXXXX [#](/topic/$xncr/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$xncr/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$xncr/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXXX +280%  
**1 Month**: XXXXXX -XX%  
**1-Year High**: XXXXXX on 2025-05-14  
**1-Year Low**: X on 2025-07-30  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: X [#](/topic/$xncr/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$xncr/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$xncr/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: XX  
**1 Month**: XX -XX%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: X on 2025-08-11  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: X [#](/topic/$xncr/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$xncr/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$xncr/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $xncr in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Month**: X -XX%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: X on 2025-08-11  

The most influential creators that mention $xncr in the last XX hours

| Creator                                          | Rank | Followers | Posts | Engagements |
| -------                                          | ---- | --------- | ----- | ----------- |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | X    | XXXXX     | X     | XXX         |

[View More](/list/creators/$xncr/100)
  
  
### Sentiment: XXX% [#](/topic/$xncr/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$xncr/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$xncr/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Month**: XXX% no change  
**1-Year High**: XXX% on 2025-04-30  
**1-Year Low**: XX% on 2025-10-04  

**Most Supportive Themes**
- **Analyst Ratings and Price Targets:** (20%) Positive analyst ratings and price targets from firms like Wedbush and Jefferies are mentioned, suggesting a positive outlook for Xencor.
- **Bullish Trend and Uptrend Continuation:** (15%) Posts indicate a weekly bullish trend, with expectations of an uptrend continuation, supported by mentions of related stocks.
- **Portfolio and 13F Filings:** (10%) Mentions in portfolio recaps and 13F filings, indicating institutional interest and potential for future growth.
  
**Most Critical Themes**
- **Negative Rating:** (30%)  A negative rating from Barclays is mentioned, which may cause short-term volatility.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | X        | X% |
  


**Top assets mentioned**
In the posts about $xncr in the last XX hours

[Regeneron Pharmaceuticals Inc (REGN)](/topic/regeneron-pharmaceuticals-inc)
[Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn)
[AbbVie Inc (ABBV)](/topic/$abbv)
[Amgen, Inc. (AMGN)](/topic/$amgn)
[Biogen Inc (BIIB)](/topic/biogen-inc)
[Biogen Inc (BIIB)](/topic/$biib)
[Bank of America (BAC)](/topic/bank-of-america)
[Wells Fargo & Co (WFC)](/topic/$wfc)
[Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/alnylam-pharmaceuticals-inc)
[Critical Metals Corp. Ordinary Shares (CRML)](/topic/$crml)

**Top topics mentioned**
In the posts about $xncr in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [stocks financial services](/topic/stocks-financial-services), [$tmq](/topic/$tmq), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$bhvn](/topic/$bhvn), [$abbv](/topic/$abbv), [$amgn](/topic/$amgn), [biogen inc](/topic/biogen-inc), [$biib](/topic/$biib), [alternative investment](/topic/alternative-investment), [$omer](/topic/$omer), [$aplm](/topic/$aplm), [$sprc](/topic/$sprc), [acquisition](/topic/acquisition), [stocks banks](/topic/stocks-banks), [bank of america](/topic/bank-of-america), [$wfc](/topic/$wfc), [$oncs](/topic/$oncs), [$cvac](/topic/$cvac), [$bntx](/topic/$bntx), [alnylam pharmaceuticals inc](/topic/alnylam-pharmaceuticals-inc), [$200m2b](/topic/$200m2b), [$nva](/topic/$nva), [$oec](/topic/$oec), [$ivvd](/topic/$ivvd), [$crml](/topic/$crml), [$nvts](/topic/$nvts), [$abat](/topic/$abat), [$eric](/topic/$eric), [$prax](/topic/$prax), [$exk](/topic/$exk), [$sli](/topic/$sli), [$gral](/topic/$gral), [$sa](/topic/$sa), [$incy](/topic/$incy), [$mrna](/topic/$mrna), [$arvn](/topic/$arvn), [$apls](/topic/$apls), [$bcax](/topic/$bcax), [$exel](/topic/$exel), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$rna](/topic/$rna), [$avnt](/topic/$avnt), [targets](/topic/targets), [bitdeer](/topic/bitdeer), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$btdr](/topic/$btdr), [commerce bancshares inc](/topic/commerce-bancshares-inc), [$xel](/topic/$xel), [xcel energy inc](/topic/xcel-energy-inc), [coins layer 1](/topic/coins-layer-1), [coins privacy](/topic/coins-privacy), [stocks utilities](/topic/stocks-utilities), [$ibrx](/topic/$ibrx), [$bmy](/topic/$bmy), [investment](/topic/investment)

### Top Social Posts [#](/topic/$xncr/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"100new $PRAX $EXK $SLI $GRAL $SA $GPRE $HMY $PSNL $MUX $HL $JBHT $PPTA $BG $GEVO $BTG $USAS $SION $GFI $ESTA $WRN $IAG $IAUX $NEM $CDE $IMNM $PACB $AEM $VICR $KYIV $SBSW $NEO $ASA $XNCR $AGI $KOPN $AVAH $SEI $KGC $YSG $DCTH $CGAU $SSRM $EGO $BLTE $XERS $DRD $VPG $TFPM"  
[X Link](https://x.com/MammaaiutoY/status/1978918261795197367) [@MammaaiutoY](/creator/x/MammaaiutoY) 2025-10-16T20:17Z XXX followers, XXX engagements


"📣 Biotech Stock News 10/15 @ Open $OMER XXX% Asset purchase & license agreement $APLM XX% Resumes Trading $SPRC XX% Acquisition Agreement $ABSI XX% KOL Seminar on ABS-201 Program $XNCR X% Ph1 Dose-Escalation Results Presented $GYRE X% Completion of Patient Enrollment in Trial $SCYX X% Disagreement Resolved on Phase X Study $NVCR X% New Research for TTFields Therapy $HIMS X% Launches Menopause & Perimenopause Specialty $TEM X% Six Abstracts Accepted for ESMO 2025 $MNPR X% Abstract Accepted for Oral Presentation $ACOG X% Presenting Clinical Data at Meetings $AUPH X% Upcoming Presentations on"  
[X Link](https://x.com/BiopharmIQ/status/1978486736369123644) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-15T15:42Z 27.4K followers, 9627 engagements


"RBC Capital Markets XNCR US - First Look at '819 Data From Leaked Abstract Suggests Interplay of CRS and Future Efficacy Will Determine Path Forward Full report in Telegram (in bio)☝ (Tickers: $XNCR $REGN $MGNX $IBRX $BMY $XOMA)"  
[X Link](https://x.com/Biobeats99/status/1978236319928066409) [@Biobeats99](/creator/x/Biobeats99) 2025-10-14T23:07Z XXX followers, XXX engagements


"$XNCR -XXXXX% today as Xencor Announces Presentation of Initial Phase X Dose-Escalation Results of XmAb819 in Clear Cell Renal Cell Carcinoma at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978213496346067120) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:37Z 2790 followers, XXX engagements